(S)-3,5-DICHLORO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-6-HYDROXY-O-ANISAMIDE
Anhedonia
University of North Carolina, Chapel HillSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
14 Active assets in the Anhedonia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
DESVENLAFAXINE Jiangsu Province Nanjing Brain Hospital | Phase 4 | BB |
17-beta-estradiol University of North Carolina, Chapel Hill | Phase 4 | BB |
TEONANACATL Medical University of Vienna | Phase 2 | BB |
Prometrium University of North Carolina, Chapel Hill | Phase 4 | BB |
Alto-203 Alto Neuroscience | Phase 2 | B |
View all 16 →
Same molecule, other indications
(S)-3,5-DICHLORO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-6-HYDROXY-O-ANISAMIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →